Reimbursed with a limitationOriginator productATC J02AA01

Ambisome

Ambisome is an originator product from Gilead Sciences Switzerland Sàrl and is listed on the FOPH Specialities List. Swiss mandatory health insurance therefore reimburses it within the authorised indication. The public price ranges from CHF 137.55 to CHF 1'227.75 depending on the pack; the patient co-payment is 10 per cent plus the deductible.

Core data

Authorisation holder
Gilead Sciences Switzerland Sàrl
ATC code
J02AA01
IT group
08.06 Mittel gegen Pilze
Active substances
Amphotericinum B liposomal
Preparation type
Originator product
On the SL since
01/04/2002
Last price change
01/12/2025
Co-payment
10%

Prices per pack

The ex-factory price is the authorisation holder's price; the public price adds the distribution share and VAT. Both are FOPH maximum prices: nothing above them may be charged.

Ambisome Price table As of 17/09/2026
Dosage formPack sizeEx-factory pricePublic priceValid fromCat.GTIN
Trockensub 50 mgDurchstf 1 StkCHF 111.38CHF 137.5501/04/2002A7680533420273
Trockensub 50 mgDurchstf 10 StkCHF 1'113.82CHF 1'227.7501/05/2020A7680533420198

Limitation

This preparation is reimbursed only under the conditions below. The text is the binding FOPH wording; outside those conditions basic insurance does not pay.

The FOPH publishes limitation texts in German, French and Italian only. The German wording is reproduced verbatim below.

FOPH wordingValid from 01/03/2019

Behandlung von schweren systemischen und/oder tiefen Mykosen durch gegenüber Amphotericin B sensible Erreger.
Empirische Behandlung von vermuteten Pilzinfektionen bei Patienten mit febriler Neutropenie.
Die Erstverschreibung darf ausschliesslich durch Fachärzte für Infektiologie oder Hämatologie erfolgen.

FAQ

Is Ambisome covered by Swiss health insurance?

Yes, but only under conditions. Ambisome is on the Specialities List with a limitation: basic insurance reimburses it only when the conditions in the limitation text are met, in some cases only after the insurer has granted cost approval.

What does Ambisome cost in Switzerland?

The public price is the maximum price set by the FOPH and for Ambisome ranges from CHF 137.55 to CHF 1'227.75 per pack. The ex-factory price ranges from CHF 111.38 to CHF 1'113.82. Pharmacies may not charge more, but may charge less.

Correct or complete this entry

Market access

Do you need your product on the Specialities List?

Questions about SL listing, prices or limitations? Contact Swiss Reimbursement.

  • Independent directory
  • Official FOPH data
  • Website in eight languages
Send an enquiry
Contact

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissreimbursement.com